A microbiological assay was developed for bleomycin, an antitumor antibiotic reported to be active in human trials. The assay bacterium was a strain of Escherichia coli which is resistant to ethionine. Studies revealed relatively high concentrations of bleomycin in the blood and urine of mice after a single dose, < 0.33 LD10, injected intraperitoneally.
A microbiological assay was developed for bleomycin, an antitumor antibiotic reported to be active in human trials. The assay bacterium was a strain of Escherichia coli which is resistant to ethionine. Studies revealed relatively high concentrations of bleomycin in the blood and urine of mice after a single dose, < 0.33 LD10, injected intraperitoneally.
Streptomyces verticullus produces a group of antibiotics originally designated as bleomycin but subsequently subdivided into bleomycin A and B (13) . In turn, bleomycin A was found to consist of six structurally closely related antibiotics, and bleomycin B was found to consist of five structurally closely related antibiotics (14) . All of the bleomycins showed marked inhibitory activity against a broad spectrum of gram-positive and gram-negative bacteria. Inhibitory activity against Ehrlich carcinoma, sarcoma 180, and other transplantable mouse ascites tumors has also been reported (5, 6, 11, 12) . Recent reports indicate that bleomycin is effective against certain types of cancer in humans (2, 3, 7, 10, 15) . Microbiological assays for bleomycin employing Mycobacteriwn phlei NIHJ (13) or Bacillus subtilis PCI219 (6) have reportedly been used in purification and pharmacological studies, but detailed descriptions of the procedures were not published. Ohnuma (4) were used to find an appropriate microorganism for the assay of bleomycin. From approximately 100 species of bacteria tested for sensitivity to this compound, a strain of E. coli ATCC9637 resistant to ethionine (designated E. coli/ETH) was selected as the assay organism because of its unique sensitivity. The culture was maintained on agar slants of a glucose-salts medium (9) supplemented with 1.0 mg of ethionine per ml. Stationary cultures of E. coli/ETH were grown for 16 to 18 hr at 37 C in glucose-salts broth, supplemented with 100,g of ETH/ml, for the preparation of seeded agar assay plates (100 by 15 mm, Lab-Tex Products, Division Miles Laboratories, Inc., Westmont, Ill.). Cells from these cultures were collected and washed twice by centrifugation in saline (0.85% NaCl), resuspended in saline, and adjusted to 20% light transmittance (660 nm) in a Spectronic-20 colorimeter (Bausch & Lomb, Inc., Rochester, N.Y.). This suspension was diluted 1:200 with saline, and 10 ml of this suspension was added to 1 liter of cooled (50 C) glucose-salts agar medium supplemented with 10 ,g of guanine per ml. Earlier studies with a variety of individual metabolites revealed that the addition of guanine to the medium increased the sensitivity of E. coli/ETH to inhibition by bleomycin. A 6-ml amount of the inoculated agar was dispensed into the previously described petri plates.
A stock solution of bleomycin was prepared in sterile saline and was suitably diluted. When 0.08 ml of the various dilutions was added to filter paper discs (1.27 cm in diameter), the experimental samples (blood or tissue homogenates) or standard-curve solutions of different concentrations. The third disc contained an empirically selected concentration of 0.1 ,ug of bleomycin per disc, which allowed for correction of plate-to-plate variation in zone sizes. The plates were preincubated for 24 hr at 100 -4 C and then in_ubated for 15 to 18 hr at 30 C. The rine preincubation storage resulted in increased sensitivity. * :
The resulting zones of inhibition on the plates were measured and corrected as previously reported (4). The corrected mean diameters of the zones of inhibi-10 Blood tion surrounding the discs, which contained known E concentrations of drug, were plotted on semilogarith-' mic graph paper, with the zones sizes on the arith-Q metic scale and drug concentrations per disc on the n logarithmic scale. Standard curves were constructed ',a through the points thus obtained by the method of > least squares (1) . Drug concentrations in the experimental samples were obtained by reading known drug concentrations on the ordinate of the blood standard curve which corresponded to the size of the corrected zones of inhibition surrounding the discs impregnated Limit of Assay Sensitivity with the tissue homogenates.
In all experiments, BDF1 mice (mixed sexes, 18 to 22 g) were used.
RESULTS AND DISCUSSION
.01, 15 Fig. 1 . In either diluent, concentrations as low as 0.1 ,g/ml could be detected. The concentrations of bleomycin detected in the blood and urine of mice, which were injected intraperitoneally with a 20 mg/kg (<0.33 LD,o) dose of drug, are shown in Fig. 2 . No bleomycin was detected in the kidneys, lung, spleen, liver, or brain of the mice under these conditions of drug administration, indicating that <0.1 ,ug of bleomycin per g of tissue was present.
